Developer docs
API playgroundTry for free, no card

Search company profiles

PAN-Biotech GmbH

Full company profile

uuid000hdy1

Namestring
PAN-Biotech GmbH
Legal namestring
PAN-Biotech GmbH
Websiteurl
pan-biotech.de
Company typeenum
Private
Founded yearint
1988
Descriptiontext

PAN-Biotech GmbH is a privately held German biotechnology company founded in 1988 and headquartered in Aidenbach, Bavaria. The company manufactures and distributes cell culture media, serum products (including FBS), serum-free media systems, reagents, buffers, water for cell culture, biologics, and cryopreservation media (Cryopan I/II/III). Its products serve research institutions and academia, clinics and healthcare providers, and biopharmaceutical companies engaged in cell and gene therapy, vaccine production, mRNA technology, and antibody manufacturing, with a secondary food technology vertical served through the PAN-Foodtech subsidiary.

The company's core technology platform centers on proprietary serum-free and chemically defined media formulations developed over more than three decades, manufactured at a single integrated facility that includes cGMP-compliant cleanrooms, cold storage, and in-house quality testing laboratories. The technology stack spans RUO to GMP grades, enabling the same supplier relationship to scale from research through clinical and commercial production. Manufacturing capacity ranges from 10L to 1000L batches, available in bottles, canisters, or single-use 2D/3D bag systems, with global cold chain distribution.

PAN-Biotech operates a hybrid product-and-service revenue model combining catalog product sales (one-time purchases via e-commerce and direct enterprise sales) with contract manufacturing/CDMO services (process development, sterile filling, OEM manufacturing) and the Scale-Up Program for biotech startups. Pricing is tiered between university customers (free shipping above €300) and industrial customers (quote-based for large or heavy orders), with standard 30-day payment terms. Distribution is global, centrally controlled from Germany, and supplemented by participation in major industry events including CPHI and Medica.

Short descriptiontext

PAN-Biotech GmbH is a privately held German manufacturer of cell culture media, sera, reagents, and cryopreservation products serving research institutions, clinics, and biopharmaceutical companies globally, with additional CDMO and Scale-Up Program services for biotech startups.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAidenbach, Germany
HQ citystring
Aidenbach
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell culture media, biopharmaceutical manufacturing, serum products, contract manufacturing services, cell therapy solutions
Industry4 codes
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAACAJ
Gene Therapy Vector Manufacturing & CDMO Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Services-Commercial Physical & Biological Research8731
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Cell Culture Media and Bioprocessing Products
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Product Sales
TypeOne Time License
Description

Sale of cell culture products including sera, media, serum-free systems, reagents, buffers, and biologicals to research institutions, clinics, and biopharmaceutical companies worldwide.

pan-biotech.de
2Contract Manufacturing / CDMO Services
TypeProfessional Services
Description

OEM and contract manufacturing services for sterile and non-sterile cell culture products. Services include process development, media fills, bulk production, and sterile filling from 10L to 1000L batches.

scaleup.pan-biotech.de
3Scale-Up Program Services
TypeManaged Services
Description

Comprehensive startup support including spin-off assistance, partnering services, and full-service business process outsourcing for biotech companies.

scaleup.pan-biotech.de
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1University Customer Pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Orders under €299.99: €14.90 shipping (without dry ice) or €34.90 (with dry ice). Orders over €300: Free shipping. Minimum order surcharge of €10 for orders under €50.

shop.pan-biotech.de
2Industrial Customer Pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Freight costs calculated by order quantity and weight. For orders over 70kg, price inquiry required. Some countries require direct price quotation rather than online ordering.

3Invoice Payment Terms
ModelOtherBilling cadenceMonthly
Notes

Payment terms: 30 days for standard orders, 14 days for online shop purchases. Late payment interest: 5% p.a.

shop.pan-biotech.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

PAN-Biotech GmbH manufactures and supplies cell culture media, sera, serum-free systems, reagents, buffers, water, biologics, and cryopreservation media for biopharmaceutical, research, and clinical applications. The company also offers CDMO/CMO contract manufacturing services, custom media development, and OEM services from RUO to GMP scale, with production batches ranging from 10L to 1000L. Its product portfolio supports cell and gene therapy, vaccine production, mRNA technology, and antibody production workflows.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PAN-Biotech GmbH is a German biotechnology company (since 1988) specializing in cell culture products and services. The product portfolio centers around a comprehensive cell culture ecosystem including: (1) Core Media Products - cell culture media (standard, insect, cell-specific), serum products (FBS, treated sera, human sera), and serum-free alternatives; (2) Reagents & Biologics - reagents (additives, buffers, enzymes, attachment factors, BSA/HSA, antibodies), water for cell culture, and biologics (cytokines, growth factors); (3) Specialty Products - cryopreservation media (Cryopan I/II/III), RNase/DNase neutralizers; (4) Application-Specific Solutions - cell and gene therapy media, vaccine production tools, mRNA technology support, and antibody production systems; (5) GMP-Grade Products - pharmaceutical-quality media and reagents for clinical applications; (6) Contract Manufacturing Services (CDMO/CMO) including single-use bag systems and scale-up support. The company operates as both a product manufacturer and service provider, offering custom media development, OEM manufacturing, and full outsourcing solutions for biotech startups and pharmaceutical companies.

Product and service1 record
1Cell Culture Media (Medien)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Supplies cell culture media, sera, and bioprocessing solutions for the biopharmaceutical industry. Overlaps with PAN-Biotech's media, serum, and CDMO offering as part of a much broader bioprocessing portfolio.

2Merck KGaA / MilliporeSigma
TypeBroad incumbent
Description

Life science tools giant offering cell culture media, sera, reagents, and biopharmaceutical CDMO services. Direct competitor in PAN-Biotech's media, reagent, and CDMO categories, with far broader product breadth.

3Corning Life Sciences
TypeBroad incumbent
Description

Supplies cell culture media, sera, and single-use bioprocessing vessels to biopharmaceutical customers. Overlaps with PAN-Biotech in media, sera, and 2D/3D bag offerings, though within a much broader life sciences portfolio.

TypeDirect peer
Description

Provides reagents, media, cytokines, and growth factors for cell culture and cell therapy applications. Comparable to PAN-Biotech's biologics, reagents, and specialty media offerings, particularly for research and translational-stage customers.

TypeBroad incumbent
Description

Provides bioprocessing equipment, cell culture media, and process solutions for biopharmaceutical manufacturing. Comparable to PAN-Biotech in upstream bioprocessing inputs, though more weighted toward filtration and equipment.

TypeDirect peer
Description

Specializes in cell culture media, sera, and CDMO services for cell and gene therapy, vaccines, and biopharmaceutical applications. Closest comparable peer to PAN-Biotech in media specialization and CDMO focus, with overlapping application areas.

TypeBroad incumbent
Description

Operates Gibco cell culture media and bioservices CDMO businesses, directly competing with PAN-Biotech's media, sera, and CDMO offerings. A broad incumbent that dwarfs PAN-Biotech in scale and global reach.

TypeBroad incumbent
Description

Global leader in biologics CDMO and cell & gene therapy manufacturing. Directly comparable to PAN-Biotech's CDMO and cell culture media offerings but at vastly greater scale across mammalian, microbial, and cell therapy modalities.

TypeDirect peer
Description

Swiss-headquartered (with German operations) supplier of enzymes, reagents, and CDMO services for the biopharmaceutical industry. Comparable in size, geographic origin, and product/service mix to PAN-Biotech's CDMO and custom media offerings.

TypeDirect peer
Description

German-headquartered supplier of GMP-grade raw materials for cell and gene therapy manufacturing, including media, cytokines, and cryopreservation solutions. Highly comparable niche player focused on the same cell therapy customer base as PAN-Biotech.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PAN-Biotech GmbH

Cell Culture Media and Bioprocessing Productspan-biotech.de

PAN-Biotech GmbH is a privately held German manufacturer of cell culture media, sera, reagents, and cryopreservation products serving research institutions, clinics, and biopharmaceutical companies globally, with additional CDMO and Scale-Up Program services for biotech startups.

What PAN-Biotech GmbH does

PAN-Biotech GmbH is a privately held German biotechnology company founded in 1988 and headquartered in Aidenbach, Bavaria. The company manufactures and distributes cell culture media, serum products (including FBS), serum-free media systems, reagents, buffers, water for cell culture, biologics, and cryopreservation media (Cryopan I/II/III). Its products serve research institutions and academia, clinics and healthcare providers, and biopharmaceutical companies engaged in cell and gene therapy, vaccine production, mRNA technology, and antibody manufacturing, with a secondary food technology vertical served through the PAN-Foodtech subsidiary.

The company's core technology platform centers on proprietary serum-free and chemically defined media formulations developed over more than three decades, manufactured at a single integrated facility that includes cGMP-compliant cleanrooms, cold storage, and in-house quality testing laboratories. The technology stack spans RUO to GMP grades, enabling the same supplier relationship to scale from research through clinical and commercial production. Manufacturing capacity ranges from 10L to 1000L batches, available in bottles, canisters, or single-use 2D/3D bag systems, with global cold chain distribution.

PAN-Biotech operates a hybrid product-and-service revenue model combining catalog product sales (one-time purchases via e-commerce and direct enterprise sales) with contract manufacturing/CDMO services (process development, sterile filling, OEM manufacturing) and the Scale-Up Program for biotech startups. Pricing is tiered between university customers (free shipping above €300) and industrial customers (quote-based for large or heavy orders), with standard 30-day payment terms. Distribution is global, centrally controlled from Germany, and supplemented by participation in major industry events including CPHI and Medica.

PAN-Biotech GmbH firmographics

Firmographics
Name
PAN-Biotech GmbH
Legal name
PAN-Biotech GmbH
Website
https://pan-biotech.de
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
11–50 employees
Short description
PAN-Biotech GmbH is a privately held German manufacturer of cell culture media, sera, reagents, and cryopreservation products serving research institutions, clinics, and biopharmaceutical companies globally, with additional CDMO and Scale-Up Program services for biotech startups.
Ownership category
akta.pro rank

PAN-Biotech GmbH industry classification

Industry
Product category
Cell Culture Media and Bioprocessing Products
NAICS
Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAACAJ
Gene Therapy Vector Manufacturing & CDMO Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)

Keywords

  • Cell culture media
  • Biopharmaceutical manufacturing
  • Serum products
  • Contract manufacturing services
  • Cell therapy solutions

Where PAN-Biotech GmbH is headquartered

Location

Headquarters

HQ city
Aidenbach
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

PAN-Biotech GmbH business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Product Sales: Sale of cell culture products including sera, media, serum-free systems, reagents, buffers, and biologicals to research institutions, clinics, and biopharmaceutical companies worldwide.
  2. Contract Manufacturing / CDMO Services: OEM and contract manufacturing services for sterile and non-sterile cell culture products. Services include process development, media fills, bulk production, and sterile filling from 10L to 1000L batches.
  3. Scale-Up Program Services: Comprehensive startup support including spin-off assistance, partnering services, and full-service business process outsourcing for biotech companies.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goUniversity Customer Pricing
Unit PricingPay-as-you-goIndustrial Customer Pricing
OtherMonthlyInvoice Payment Terms

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

PAN-Biotech GmbH product offering

Product offering

Core offering

PAN-Biotech GmbH manufactures and supplies cell culture media, sera, serum-free systems, reagents, buffers, water, biologics, and cryopreservation media for biopharmaceutical, research, and clinical applications. The company also offers CDMO/CMO contract manufacturing services, custom media development, and OEM services from RUO to GMP scale, with production batches ranging from 10L to 1000L. Its product portfolio supports cell and gene therapy, vaccine production, mRNA technology, and antibody production workflows.

Product overview

PAN-Biotech GmbH is a German biotechnology company (since 1988) specializing in cell culture products and services. The product portfolio centers around a comprehensive cell culture ecosystem including: (1) Core Media Products - cell culture media (standard, insect, cell-specific), serum products (FBS, treated sera, human sera), and serum-free alternatives; (2) Reagents & Biologics - reagents (additives, buffers, enzymes, attachment factors, BSA/HSA, antibodies), water for cell culture, and biologics (cytokines, growth factors); (3) Specialty Products - cryopreservation media (Cryopan I/II/III), RNase/DNase neutralizers; (4) Application-Specific Solutions - cell and gene therapy media, vaccine production tools, mRNA technology support, and antibody production systems; (5) GMP-Grade Products - pharmaceutical-quality media and reagents for clinical applications; (6) Contract Manufacturing Services (CDMO/CMO) including single-use bag systems and scale-up support. The company operates as both a product manufacturer and service provider, offering custom media development, OEM manufacturing, and full outsourcing solutions for biotech startups and pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cell Culture Media (Medien)

Companies that use PAN-Biotech GmbH

Customer profile

Segments4 records

Ideal customer profiles3 records

PAN-Biotech GmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

PAN-Biotech GmbH partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

PAN-Biotech GmbH competitors and assessment

Company assessment

Broad incumbents

  • Cytiva (Danaher): Supplies cell culture media, sera, and bioprocessing solutions for the biopharmaceutical industry. Overlaps with PAN-Biotech's media, serum, and CDMO offering as part of a much broader bioprocessing portfolio.
  • Merck KGaA / MilliporeSigma: Life science tools giant offering cell culture media, sera, reagents, and biopharmaceutical CDMO services. Direct competitor in PAN-Biotech's media, reagent, and CDMO categories, with far broader product breadth.
  • Corning Life Sciences: Supplies cell culture media, sera, and single-use bioprocessing vessels to biopharmaceutical customers. Overlaps with PAN-Biotech in media, sera, and 2D/3D bag offerings, though within a much broader life sciences portfolio.
  • Sartorius AG: Provides bioprocessing equipment, cell culture media, and process solutions for biopharmaceutical manufacturing. Comparable to PAN-Biotech in upstream bioprocessing inputs, though more weighted toward filtration and equipment.
  • Thermo Fisher Scientific: Operates Gibco cell culture media and bioservices CDMO businesses, directly competing with PAN-Biotech's media, sera, and CDMO offerings. A broad incumbent that dwarfs PAN-Biotech in scale and global reach.
  • Lonza Group AG: Global leader in biologics CDMO and cell & gene therapy manufacturing. Directly comparable to PAN-Biotech's CDMO and cell culture media offerings but at vastly greater scale across mammalian, microbial, and cell therapy modalities.

Direct peers

  • Bio-Techne Corporation: Provides reagents, media, cytokines, and growth factors for cell culture and cell therapy applications. Comparable to PAN-Biotech's biologics, reagents, and specialty media offerings, particularly for research and translational-stage customers.
  • FUJIFILM Irvine Scientific: Specializes in cell culture media, sera, and CDMO services for cell and gene therapy, vaccines, and biopharmaceutical applications. Closest comparable peer to PAN-Biotech in media specialization and CDMO focus, with overlapping application areas.
  • Biosynth (formerly c-LEcta): Swiss-headquartered (with German operations) supplier of enzymes, reagents, and CDMO services for the biopharmaceutical industry. Comparable in size, geographic origin, and product/service mix to PAN-Biotech's CDMO and custom media offerings.
  • CellGenix GmbH: German-headquartered supplier of GMP-grade raw materials for cell and gene therapy manufacturing, including media, cytokines, and cryopreservation solutions. Highly comparable niche player focused on the same cell therapy customer base as PAN-Biotech.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

PAN-Biotech GmbH social profiles

Digital presence

PAN-Biotech GmbH compliance and trust

Trust signal

Compliance6 records

PAN-Biotech GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PAN-Biotech GmbH leadership team

Management profile

Number of profiles

Profiles2 records

PAN-Biotech GmbH subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PAN-Biotech GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PAN-Biotech GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PAN-Biotech GmbH

What does PAN-Biotech GmbH do?

PAN-Biotech GmbH manufactures and supplies cell culture media, sera, serum-free systems, reagents, buffers, water, biologics, and cryopreservation media for biopharmaceutical, research, and clinical applications. The company also offers CDMO/CMO contract manufacturing services, custom media development, and OEM services from RUO to GMP scale, with production batches ranging from 10L to 1000L. Its product portfolio supports cell and gene therapy, vaccine production, mRNA technology, and antibody production workflows.

Is PAN-Biotech GmbH a public or private company?

PAN-Biotech GmbH is a private company. It is classified as management employee owned and is currently operating.

When was PAN-Biotech GmbH founded?

PAN-Biotech GmbH was founded in 1988. It employs 11 to 50 people.

Where is PAN-Biotech GmbH based?

PAN-Biotech GmbH is headquartered in Aidenbach, Germany, in the Europe region.

How does PAN-Biotech GmbH make money?

Three revenue lines are on record. Product Sales are the primary driver. The others are contract Manufacturing / CDMO Services and scale-Up Program Services.

Who are PAN-Biotech GmbH's main competitors?

Broad incumbents on record are Cytiva (Danaher), Merck KGaA / MilliporeSigma, Corning Life Sciences, Sartorius AG, Thermo Fisher Scientific and Lonza Group AG. Direct peers are Bio-Techne Corporation, FUJIFILM Irvine Scientific, Biosynth (formerly c-LEcta) and CellGenix GmbH.

Does PAN-Biotech GmbH have an API?

No public API is recorded for PAN-Biotech GmbH.

What industry is PAN-Biotech GmbH in?

PAN-Biotech GmbH's product category is Cell Culture Media and Bioprocessing Products. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals